ASILX vs. BIVRX
Compare and contrast key facts about AB Select US Long/Short Portfolio (ASILX) and Invenomic Fund (BIVRX).
ASILX is managed by AllianceBernstein. It was launched on Dec 11, 2012. BIVRX is managed by Invenomic. It was launched on Jun 18, 2017.
Performance
ASILX vs. BIVRX - Performance Comparison
Loading graphics...
ASILX vs. BIVRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ASILX AB Select US Long/Short Portfolio | -2.41% | 9.77% | 18.46% | 11.06% | -9.94% | 17.81% | 10.23% | 17.17% | -1.61% | 7.57% |
BIVRX Invenomic Fund | 5.94% | 4.39% | -9.03% | 16.47% | 49.61% | 44.06% | 11.12% | 11.36% | 3.41% | 8.73% |
Returns By Period
In the year-to-date period, ASILX achieves a -2.41% return, which is significantly lower than BIVRX's 5.94% return.
ASILX
- 1D
- -0.07%
- 1M
- -2.68%
- YTD
- -2.41%
- 6M
- -1.15%
- 1Y
- 7.77%
- 3Y*
- 11.88%
- 5Y*
- 7.29%
- 10Y*
- 8.41%
BIVRX
- 1D
- 3.43%
- 1M
- 2.62%
- YTD
- 5.94%
- 6M
- 11.17%
- 1Y
- 6.87%
- 3Y*
- 1.70%
- 5Y*
- 13.81%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
ASILX vs. BIVRX - Expense Ratio Comparison
ASILX has a 1.55% expense ratio, which is lower than BIVRX's 2.48% expense ratio.
Return for Risk
ASILX vs. BIVRX — Risk / Return Rank
ASILX
BIVRX
ASILX vs. BIVRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AB Select US Long/Short Portfolio (ASILX) and Invenomic Fund (BIVRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ASILX | BIVRX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.23 | 0.32 | +0.92 |
Sortino ratioReturn per unit of downside risk | 1.72 | 0.65 | +1.07 |
Omega ratioGain probability vs. loss probability | 1.25 | 1.07 | +0.18 |
Calmar ratioReturn relative to maximum drawdown | 2.01 | 0.41 | +1.59 |
Martin ratioReturn relative to average drawdown | 7.16 | 0.93 | +6.22 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ASILX | BIVRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.23 | 0.32 | +0.92 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.91 | 0.82 | +0.09 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.91 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.91 | 0.91 | 0.00 |
Correlation
The correlation between ASILX and BIVRX is 0.03, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
ASILX vs. BIVRX - Dividend Comparison
ASILX's dividend yield for the trailing twelve months is around 13.48%, more than BIVRX's 1.82% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASILX AB Select US Long/Short Portfolio | 13.48% | 13.15% | 7.18% | 1.41% | 6.51% | 11.92% | 4.28% | 3.54% | 8.71% | 5.03% | 0.00% | 3.35% |
BIVRX Invenomic Fund | 1.82% | 1.93% | 3.55% | 20.26% | 28.43% | 3.00% | 3.11% | 3.21% | 4.82% | 1.21% | 0.00% | 0.00% |
Drawdowns
ASILX vs. BIVRX - Drawdown Comparison
The maximum ASILX drawdown since its inception was -18.36%, roughly equal to the maximum BIVRX drawdown of -18.29%. Use the drawdown chart below to compare losses from any high point for ASILX and BIVRX.
Loading graphics...
Drawdown Indicators
| ASILX | BIVRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -18.36% | -18.29% | -0.07% |
Max Drawdown (1Y)Largest decline over 1 year | -3.62% | -13.79% | +10.17% |
Max Drawdown (5Y)Largest decline over 5 years | -12.30% | -17.66% | +5.36% |
Max Drawdown (10Y)Largest decline over 10 years | -18.36% | — | — |
Current DrawdownCurrent decline from peak | -3.61% | -1.19% | -2.42% |
Average DrawdownAverage peak-to-trough decline | -2.49% | -5.91% | +3.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.01% | 6.14% | -5.13% |
Volatility
ASILX vs. BIVRX - Volatility Comparison
The current volatility for AB Select US Long/Short Portfolio (ASILX) is 1.16%, while Invenomic Fund (BIVRX) has a volatility of 7.61%. This indicates that ASILX experiences smaller price fluctuations and is considered to be less risky than BIVRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ASILX | BIVRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.16% | 7.61% | -6.45% |
Volatility (6M)Calculated over the trailing 6-month period | 4.00% | 16.65% | -12.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 6.59% | 20.73% | -14.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 8.04% | 16.96% | -8.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 9.30% | 17.09% | -7.79% |